Jansen-de Vries syndrome: Expansion of the PPM1D clinical and phenotypic spectrum in 34 families
- PMID: 37183572
- PMCID: PMC10330231
- DOI: 10.1002/ajmg.a.63226
Jansen-de Vries syndrome: Expansion of the PPM1D clinical and phenotypic spectrum in 34 families
Abstract
Jansen-de Vries syndrome (JdVS) is a neurodevelopmental condition attributed to pathogenic variants in Exons 5 and 6 of PPM1D. As the full phenotypic spectrum and natural history remain to be defined, we describe a large cohort of children and adults with JdVS. This is a retrospective cohort study of 37 individuals from 34 families with disease-causing variants in PPM1D leading to JdVS. Clinical data were provided by treating physicians and/or families. Of the 37 individuals, 27 were male and 10 female, with median age 8.75 years (range 8 months to 62 years). Four families document autosomal dominant transmission, and 32/34 probands were diagnosed via exome sequencing. The facial gestalt, including a broad forehead and broad mouth with a thin and tented upper lip, was most recognizable between 18 and 48 months of age. Common manifestations included global developmental delay (35/36, 97%), hypotonia (25/34, 74%), short stature (14/33, 42%), constipation (22/31, 71%), and cyclic vomiting (6/35, 17%). Distinctive personality traits include a hypersocial affect (21/31, 68%) and moderate-to-severe anxiety (18/28, 64%). In conclusion, JdVS is a clinically recognizable neurodevelopmental syndrome with a characteristic personality and distinctive facial features. The association of pathogenic variants in PPM1D with cyclic vomiting bears not only medical attention but also further pathogenic and mechanistic evaluation.
Keywords: Jansen-de Vries syndrome; PPM1D; cyclic vomiting; developmental delay; hypersocial personality.
© 2023 Wiley Periodicals LLC.
Conflict of interest statement
Figures
Similar articles
-
Novel truncating variant of PPM1D penultimate exon in a Chinese patient with Jansen-de Vries syndrome.Mol Genet Genomic Med. 2020 Mar;8(3):e1120. doi: 10.1002/mgg3.1120. Epub 2020 Jan 8. Mol Genet Genomic Med. 2020. PMID: 31916397 Free PMC article.
-
Short stature leads to a diagnosis of Jansen-de Vries syndrome in two unrelated Taiwanese girls: A case report and literature review.J Formos Med Assoc. 2022 Apr;121(4):856-860. doi: 10.1016/j.jfma.2021.12.022. Epub 2022 Jan 10. J Formos Med Assoc. 2022. PMID: 35016835 Review.
-
Jansen de Vries syndrome: Report of four new patients and review of the literature.Eur J Med Genet. 2023 Aug;66(8):104807. doi: 10.1016/j.ejmg.2023.104807. Epub 2023 Jun 28. Eur J Med Genet. 2023. PMID: 37385405 Review.
-
De Novo Truncating Mutations in the Last and Penultimate Exons of PPM1D Cause an Intellectual Disability Syndrome.Am J Hum Genet. 2017 Apr 6;100(4):650-658. doi: 10.1016/j.ajhg.2017.02.005. Epub 2017 Mar 23. Am J Hum Genet. 2017. PMID: 28343630 Free PMC article.
-
Next-generation phenotyping using computer vision algorithms in rare genomic neurodevelopmental disorders.Genet Med. 2019 Aug;21(8):1719-1725. doi: 10.1038/s41436-018-0404-y. Epub 2018 Dec 20. Genet Med. 2019. PMID: 30568311 Free PMC article.
Cited by
-
SOD1 is a synthetic lethal target in PPM1D-mutant leukemia cells.bioRxiv [Preprint]. 2024 Jan 17:2023.08.31.555634. doi: 10.1101/2023.08.31.555634. bioRxiv. 2024. Update in: Elife. 2024 Jun 18;12:RP91611. doi: 10.7554/eLife.91611 PMID: 37693622 Free PMC article. Updated. Preprint.
-
At-Risk Genomic Findings for Pediatric-Onset Disorders From Genome Sequencing vs Medically Actionable Gene Panel in Proactive Screening of Newborns and Children.JAMA Netw Open. 2023 Jul 3;6(7):e2326445. doi: 10.1001/jamanetworkopen.2023.26445. JAMA Netw Open. 2023. PMID: 37523181 Free PMC article.
-
SOD1 is a synthetic-lethal target in PPM1D-mutant leukemia cells.Elife. 2024 Jun 18;12:RP91611. doi: 10.7554/eLife.91611. Elife. 2024. PMID: 38896450 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
